Rhythmical contractions in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats. 2003

Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
Department of Cellular and Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka City, Shizuoka 422-8526, Japan.

Rhythmical contractions accompanied by an increase in cytosolic Ca2+ concentrations were produced in ring preparations of endothelium-denuded pulmonary arteries from monocrotaline-treated rats, but not in those from vehicle-treated rats, 2-3 h after a resting tension of 15 mN (150-180% of the initial wall length of the artery) was applied. The rhythmical contractions were abolished by nicardipine and ryanodine. Cyclopiazonic acid reduced the relaxation phase of the rhythmical contractions, finally leading to a sustained contraction. Similarly, apamin caused a sustained contraction, whereas charybdotoxin increased the amplitude of the rhythmical contractions. Glibenclamide had no apparent effects on them. Indomethacin and the prostaglandin H2/thromboxane A2 receptor antagonist SQ29548 abolished the rhythmical contractions and reduced the tension, but the thromboxane synthase inhibitor ozagrel had no effect. These results suggest that optimal stretch induces rhythmical contractions in the pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats, to which both Ca2+ influx through voltage-operated Ca2+ channels and Ca2+ release from the endoplasmic reticulum seem to contribute. It is also suggested that small-conductance Ca(2+)-activated K+ channels participate in the relaxation phase of rhythmical contractions. Furthermore, prostaglandin H2 released from nonendothelial cells is likely to play a pivotal role in the induction of rhythmical contractions.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008297 Male Males
D010507 Periodicity The tendency of a phenomenon to recur at regular intervals; in biological systems, the recurrence of certain activities (including hormonal, cellular, neural) may be annual, seasonal, monthly, daily, or more frequently (ultradian). Cyclicity,Rhythmicity,Biological Rhythms,Bioperiodicity,Biorhythms,Biological Rhythm,Bioperiodicities,Biorhythm,Cyclicities,Periodicities,Rhythm, Biological,Rhythmicities,Rhythms, Biological
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014661 Vasoconstriction The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE. Vasoconstrictions
D016232 Endothelins 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. Endothelium-Derived Vasoconstrictor Factors,Endothelin,Vasoconstrictor Factors, Endothelium-Derived
D016686 Monocrotaline A pyrrolizidine alkaloid and a toxic plant constituent that poisons livestock and humans through the ingestion of contaminated grains and other foods. The alkaloid causes pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature. Significant attenuation of the cardiopulmonary changes are noted after oral magnesium treatment. Monocrotaline Hydrochloride (13alpha,14alpha)-Isomer,Monocrotaline, (all-xi)-Isomer
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
January 2017, Clinical and experimental hypertension (New York, N.Y. : 1993),
Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
February 2010, The Journal of pharmacology and experimental therapeutics,
Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
January 2012, American journal of physiology. Cell physiology,
Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
September 2021, Journal of pharmacological sciences,
Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
January 1990, Microcirculation, endothelium, and lymphatics,
Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
August 1993, Acta paediatrica Japonica : Overseas edition,
Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
November 1988, Research communications in chemical pathology and pharmacology,
Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
October 2000, American journal of physiology. Heart and circulatory physiology,
Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
August 1996, Japanese circulation journal,
Akihiko Kiyoshi, and Tomohisa Ishikawa, and Ken-ichi Hayashi, and Yoshiyuki Iwatsuki, and Kunio Ishii, and Koichi Nakayama
November 2016, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology,
Copied contents to your clipboard!